Delivery Order SPE2DB22D3301-SPE2DB25FX4BG

Award Date 10/21/24
Potential Completion Date 10/22/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,794.36 firm-fixed-price delivery order is for the supply of 4,565,059,491 units of epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,046.95 firm fixed-price delivery order is for the supply of 4,566,749,551 units of epinephrine 0.3 mg auto-injectors, with a completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award is for the delivery of 4,566,708,687 units of epinephrine 0.3 mg auto-injectors. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,642.89. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,558,136,807 units of epinephrine 0.3 mg auto-injector 2S. The $11,066.43 firm fixed-price delivery order has an ultimate completion date of August 18, 2022. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The $5,916.24 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,577.83 Firm Fixed Price Delivery Order is for the supply of 4,566,699,028 units of Epinephrine 0.3 mg Auto-Injectors. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,836.14 firm-fixed-price delivery order is for the supply of 4,566,306,986 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a...
This contract award is for the delivery of 4,566,812,733 units of 0.3 mg epinephrine auto-injector devices. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,422.17, is a firm fixed-price delivery order contract with a completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,283.36 firm fixed-price delivery order is for the supply of 4,568,159,963 units of Epinephrine 0.3 mg auto-injectors. The contract has an ultimate completion date of May 7, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,789,829 units of epinephrine 0.3 mg auto-injectors. The $2,532.43 firm fixed-price delivery order contract has a completion date of December 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4BG
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp for the supply of 4,566,166,872 units of 0.3 mg epinephrine auto-injectors. The $4,288.70 firm fixed-price contract has an ultimate completion date of October 22, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely one of many delivery orders issued against that larger IDC.

The contract award contains no set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. This contract supports the DLA's mission of providing medical supplies and pharmaceuticals to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 1/26/25, 12:03 AM